Retirement Systems of Alabama Decreases Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Retirement Systems of Alabama reduced its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 0.7% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 26,793 shares of the company’s stock after selling 201 shares during the period. Retirement Systems of Alabama’s holdings in Henry Schein were worth $1,835,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of HSIC. Invesco Ltd. boosted its holdings in Henry Schein by 0.4% in the 4th quarter. Invesco Ltd. now owns 4,963,409 shares of the company’s stock valued at $343,468,000 after purchasing an additional 17,552 shares during the period. FMR LLC increased its position in shares of Henry Schein by 6.6% in the fourth quarter. FMR LLC now owns 3,498,033 shares of the company’s stock valued at $242,064,000 after acquiring an additional 217,143 shares during the period. Geode Capital Management LLC increased its position in shares of Henry Schein by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company’s stock valued at $218,762,000 after acquiring an additional 14,876 shares during the period. Palestra Capital Management LLC bought a new stake in shares of Henry Schein during the 4th quarter valued at about $182,988,000. Finally, Fiduciary Management Inc. WI boosted its stake in shares of Henry Schein by 7.2% during the 4th quarter. Fiduciary Management Inc. WI now owns 2,488,335 shares of the company’s stock valued at $172,193,000 after purchasing an additional 167,990 shares in the last quarter. 96.62% of the stock is owned by institutional investors.

Henry Schein Trading Up 0.5%

Shares of HSIC opened at $73.15 on Friday. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $82.49. The company has a 50-day moving average of $69.59 and a 200 day moving average of $71.24. The firm has a market capitalization of $8.90 billion, a price-to-earnings ratio of 22.86, a PEG ratio of 2.35 and a beta of 0.86. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.38 and a quick ratio of 0.75.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.04. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. The company had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. During the same quarter last year, the business posted $1.10 EPS. The firm’s revenue for the quarter was down .1% on a year-over-year basis. On average, research analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current year.

Analyst Ratings Changes

Several research analysts have recently issued reports on HSIC shares. Piper Sandler dropped their target price on shares of Henry Schein from $83.00 to $77.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 30th. Barrington Research reduced their price objective on shares of Henry Schein from $90.00 to $86.00 and set an “outperform” rating for the company in a research note on Tuesday, May 6th. Wells Fargo & Company cut their target price on shares of Henry Schein from $80.00 to $75.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 6th. Finally, Wall Street Zen lowered shares of Henry Schein from a “buy” rating to a “hold” rating in a research report on Thursday, April 17th. Six equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $79.30.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.